Loading…
Loading grant details…
| Funder | EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT |
|---|---|
| Recipient Organization | University of Virginia |
| Country | United States |
| Start Date | Aug 01, 2024 |
| End Date | Jul 31, 2026 |
| Duration | 729 days |
| Number of Grantees | 3 |
| Roles | Principal Investigator; Co-Investigator |
| Data Source | NIH (US) |
| Grant ID | 10887951 |
Congenital heart disease (CHD) is the most common birth defect that affects nearly 1 in 100 liveborn infants. Heterotaxy (HTX) is a severe form affecting 3-4% of CHD patients where left- right (LR) asymmetry of internal organs is not established correctly. Epidemiological studies suggest that genetics plays a significant role in CHD. Uncovering the genetic pathogenesis for
CHD is essential to provide a more accurate prognosis for CHD-related interventions, assess the risk for neurodevelopmental delays, and counsel families about recurrence risks. However, infants that undergo clinical genetic testing, known mutations and genes that cause CHD are identified in
University of Virginia
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant